FutureFuel Q3 GAAP EPS of -$0.19, revenue of $104.68M

FutureFuel reported Q3 GAAP EPS of -$0.19 and revenue of $104.68M, up 361.1% Y/Y. The increase was attributed to resumed manufacturing and regulatory clarity. Chemical segment revenue rose 9.0% to $16.92M. Adjusted EBITDA was -$4.93M, with cash equivalents at $21.33M.

Original reporting
Published Nov 9, 2026, 9:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FutureFuel Q3 GAAP EPS of -$0.19, revenue of $104.68M — source image
Decision brief

The 30-second read

$FFBearishMed
01

Why it matters

The Q3 loss and modest revenue growth suggest short-term weakness but may hint at a longer-term recovery path.

02

Market read

Micro-cap earnings miss likely drives immediate sell pressure, with limited broader market effect.

03

What to watch

Potential regulatory clarity and restart of manufacturing could improve margins later.

Relevance 6/10Novelty 7/10Timing: after-hours

Background

FutureFuel Corp (FF) is a specialty chemicals company focused on advanced materials.

Company-level read

Ticker impact

$FFBearishHigh confidence
Context

FutureFuel reported Q3 GAAP EPS of -$0.19 and revenue of $104.68M, a first-time disclosure of its quarterly results.

Expected impact

downward pressure as investors price in the loss and modest revenue growth

Evidence & confidence

The company posted a loss per share and negative adjusted EBITDA, indicating weak profitability.

Market effects

Chemical sector may see slight downside as a peer reports weaker earnings.

US small-cap investors may adjust exposure to niche chemical manufacturers.

Limited; impact confined to niche investors.

Counterpoint

If the revenue surge signals a turnaround, the stock could rebound on future quarters.

Key entities

  • FutureFuel Corp

    Issuer of the earnings release.

Related articles

$FFMed

FUTUREFUEL ANNOUNCES THIRD QUARTER 2026 RESULTS

FutureFuel Corp. (FF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FUTUREFUEL ANNOUNCES THIRD QUARTER 2026 RESULTS BATESVILLE, Ark., November 9, 2026 – FutureFuel Corp . (NYSE: FF) (“FutureFuel” or the “Company”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the third quarter

$FFMed

More than 300 robots are expected to sell and ship in October, a monthly record for the acquired business.

FFR completed its acquisition of FFAI’s robotics business, issuing shares to Smart Technology Holdings. It expects to sell over 300 robots in October, a monthly record. FFR issued 2026 guidance, projecting 2,000 robot sales with positive unit gross margins. The company announced strategic partnerships and management changes, aiming to become a leader in robotics education and Physical AI.

$FFMedAI 8/10

Jia Yueting Launches Another Capital Play: Faraday Future's Robotics Arm to List on Nasdaq via $200 Million Reverse Merger

Faraday Future's (FF) robotics arm will list on Nasdaq via a $200M reverse merger with AIxC, renaming to FF EAI Robotics Ecosystem Inc. (FFR). FF will be the largest shareholder. The robotics unit has shipped 552 units, with $1.52M revenue, targeting $1.98B in five years. FF's EV business struggles with low deliveries and cash burn.

$FFMedAI 8/10

Biofuel Stock FutureFuel Corp. (NYSE: FF) Soars on Strong Second Quarter

FutureFuel Corp. (NYSE: FF) shares rose after it reported Q2 2026 results. The company said total revenue was $78.7 million, up 120.6% year over year, with GAAP net income of $11.4 million ($0.25 diluted) and adjusted EBITDA of $11.8 million. It also cited higher chemicals and biofuel revenue, improved production, and expects positive full-year 2026 adjusted EBITDA.

$FFMedAI 8/10

Why is FutureFuel stock surging today?

Investing.com reports FutureFuel Corp. shares rose 21.5% in pre-open trading after its Q2 2026 results. The company posted $78.7M revenue, up over 120% year over year, GAAP net income of $11.4M ($0.25/diluted share), and Adjusted EBITDA of $11.8M versus a $14.2M net loss in Q2 2025. Management cited stronger Chemicals demand and improved Biofuels regulation, reaffirming full-year 2026 guidance.